TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Earning Call Transcript
Conference/Earnings Calls Alerts
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
Audio Recording of Conference call with Analysts / Investors on Financial Results for the quarter and half year ended 30th September, 2024.
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Transcript of Conference Call with Analysts / Investors on Audited Financial Results for the quarter and year ended 31st March, 2024
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
BSE India
In continuation to our letter dated 10-May-24 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Audited Financial Results of the Company for the quarter and year ended 31st March, 2024, has been placed on the Company's website at https://www.torrentpharma.com/pdf/investors/Audio_Recording31032024.mp3
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
Transcript of Conference Call with Analysts / Investor on Financial Results for the quarter and nine months ended 31st December, 2023